Table 3 Results - clinical course 1 h and 24 h after BAL procedure
Before BAL | 1 h after BAL | 24 h after BAL | |
|---|---|---|---|
PaO2/FiO2 [kPa] | 29 (CI 25–32) | 25 (CI 23–29) p < 0.05 | 31 (CI 27–33) |
PaO2/FiO2 [mmHg] | 218 (CI 188–240) | 189 (CI 173–218) | 233 (CI 203–248) |
PaO2/FiO2 decreased >25 % baseline [% of patients] | 29 % | 14 % | |
PEEP mean [cmH2O] | 9.4 (CI 9.1–9.8) | 9.6 (CI 9.2–9.9) | 9.6 (CI 9.2–10) |
PEEP increased | 7 % | 15 % | |
FiO2 mean [%] | 52 (CI 49–55) | 54 (CI 51–57) | 43 (CI 41–46) p < 0.0001 |
FiO2 increased ≥ 10 % baseline [% of patients] | 27 % | 8 % | |
pH mean | 7.41 (CI 7.40–7.42) | 7.40 (CI 7.39–7.41) | 7.41 (CI 7.40–7.42) |
pCO2 mean [kPa] | 5.2 (CI 5.0–5.4) | 5.4 (CI 5.2–5.6) | 5.2 (CI 5.0–5.4) |
pCO2 mean [mmHg] | 39 (CI 38–41) | 41 (CI 39–42) | 39 (CI 38–41) |
MAP mean [mmHg] | 84 (CI 81–86) | 79 (CI 76–81) | 83 (CI 81–86) |
Heart rate mean [beats/min] | 96 (CI 93–100) | 94 (CI 93–99) | 91 (CI 88–94) |
Norepinephrine [% of patients] | 58 % | 57 % | 62 % |
Norepinephrine median | 0.125 | 0.109 | 0.125 |
1. quartile/3. Quartile [μg/kg/min] | 0.050/0.201 | 0.075/0.202 | 0.068/0.219 |
Dobutamine [% of patients] | 3 % | 3 % | 3 % |
Dobutamine median | 5 | 5 | 3 |
1. quartile/3. Quartile [μg/kg/min] | 3/5 | 2/5 | 3/5 |
Hemodynamic instabilitya[% of patients] | 5 % | 7 % | |
Hemodynamic instabilitya at any time within 24 h [% of patients] | 22 % |